NCT00184951View on ClinicalTrials.gov

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
HIV InfectionsHyperlipidemia
Interventions
DRUG

Rosuvastatin

Trial Locations (5)

Unknown

University of Bonn, Bonn

University of Cologne, Cologne

University of Amsterdam, Amsterdam

University of Leiden, Leiden

University of Nijmegen, Nijmegen

Sponsors

Collaborators (2)

Abbott
AstraZeneca
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

lead

Radboud University Medical Center

OTHER